Nice headline, but low grade, and come from 10 plus lodes, complex inground... Summary is they made their effort, compared to NST alaska acquisition, u know what investors are willing pay for... Grade is king!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%